Abbvie Inc (NYSE:ABBV) over-valued by 12%
| Website | https://www.abbvie.com/ |
| Sector | Healthcare |
| Industry | Drug Manufacturers General |
| Fiscal Year End | Dec 31, 2020 |
| Market Cap | $205,640,990,720 |
| Beta | 0.805347 |
| Average Volume | $6,902,376 |
| Last Dividend | 4.96% |
| Price on May 7, 2021 | $116.43 |
| Autochartist™ Valuation | $102.60 |
| Conclusion |
12% over-valued |
| Download Report |
